By: Lecia Bushak
Kite Pharma will build on its previous collaboration with Arcellx to pick up ACLX-001, a BCMA-targeted CAR-T cell therapy for multiple myeloma.
Lecia Bushak is a Senior Reporter at MM+M (Medical Marketing & Media), where she covers health care topics. With a background in journalism and a creative side, Lecia brings a unique perspective to her reporting. Her work has appeared in various publications, including PRWeek and Campaign US.
This information evolves through machine learning and human feedback. Improve this profile .